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Abstract 11 
As synthetic biology moves away from “trial and error" and embraces more formal processes, 12 
workflows have emerged that extend from the conceptualisation of a genetic device to its 13 
construction and measurement. We are particularly interested in this latter aspect (i.e., 14 
characterisation and measurement of synthetic genetic devices), as this is a workflow component 15 
that has received relatively little attention, but is crucial to the success of such constructions. We 16 
present an end-to-end use case for engineering a basic synthetic construct, which is supported by 17 
information standards and computational methods, and which focuses on characterisation and 18 
measurement. This workflow captures the main stages of genetic circuit design and description, 19 
and offers standardised tools for both population-based measurement and single-cell analysis.  20 
The main contributions of the current paper are (1) Consideration of specific vector features. 21 
Although circuit design has been successfully automated, important structural information is 22 
usually overlooked, as is the case of plasmid vectors. We advocate the use of the Standard 23 
European Vector Architecture to select the optimal carrier for a design and a thorough description, 24 
in order to unequivocally correlate digital definitions and molecular devices. We developed a 25 
digital version of this plasmid format with the Synthetic Biology Open Language and a software 26 
2 
tool that allows the user to embed genetic parts in vector cargoes. This enables the annotation of a 27 
mathematical model of the circuit’s kinetic reactions formatted with the Systems Biology Markup 28 
Language. From that point onwards the experimental results and their in silico counterparts 29 
proceed alongside, with constant feedback to preserve consistency between them; (2) A 30 
framework for the calibration of fluorescence-based measurements in synthetic biology. One of 31 
the hardest endeavours in standardisation, metrology, is addressed by reinterpreting the 32 
experimental output in light of simulation results, allowing us to turn arbitrary fluorescent units 33 
into relative measurements; (3) Integration of single-cell methods into a framework for 34 
multicellular simulation and measurement, allowing for standardised consideration of the 35 
interplay between the carrier chassis and culture conditions. 36 
Introduction 37 
Synthetic biology is concerned with the rational design and construction of biological 38 
information processing devices.1 The rigorous application of engineering principles and 39 
processes is fundamental to the success of this endeavour,2,3,4 and significant attention is now 40 
being paid to the development of standardised workflows,5,6 which describe sequences of 41 
biological and algorithmic processes required to obtain a desired outcome. Such workflows, 42 
therefore, specify a “ tool-chain" for synthetic biology, and the anticipated benefits of using them 43 
include modularity (allowing individual processes to be implemented in several different ways), 44 
robustness and scalability .  45 
One of the over-arching challenges for the field is the end-to-end automation of “biodesign",7,8 a 46 
process that is made up of two main stages:6 (1) the automatic selection and/or construction of 47 
biological components, and their assembly into a network that, in principle, performs information 48 
processing according to a high-level specification, and (2) the fine-tuning of the system 49 
components and/or architecture to obtain the desired performance. The first part of this process 50 
concerns the detailed specification of the components to be used 9,10 (or fabricated 11,12,13), 51 
the attendant data representation and storage issues,14 and the correct arrangement of 52 
components into a circuit that can implement a given (logical) function. A wealth of so-called 53 
“bio-CAD" tools now exist for this latter task,15,16 and these include SBROME,17,18 54 
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TinkerCell,19 and SynBioSS.20 In terms of “fine-tuning" (the second stage), recent 55 
developments use post-assembly modification of constructs based on observed network 56 
behaviour6 or the “evolution" of cell models,21 facilitating an iterative “homing in" approach 57 
towards circuit design.  58 
In this paper, we focus on the latter stages of the circuit engineering process (that is, the 59 
implementation stages that follow the initial development of a circuit design). The specific issues 60 
that we address with our workflow (and, therefore, the most significant contributions of the paper) 61 
are (1) the formalisation of circuit description, (2) the effect of plasmid vectors on circuit 62 
performance, and (3) the correlation of experimental observations with simulation results. We 63 
now briefly discuss each of these.  64 
The first stage in the post-design process is to formalise the descriptions and sequences of the 65 
parts of the system to be constructed. An early technical standard for the description of biological 66 
parts was the BioBrick,22,23, which is appropriate for the assembly of DNA segments. However, 67 
a key consideration (which is not handled particularly well by early standards) is the variety of 68 
plasmid vectors that are available for the delivery of biological parts. Importantly, the choice of 69 
plasmid vector can dramatically affect the performance of an engineered circuit; plasmid features 70 
such as replication origin, selection markers and expression system need to be carefully 71 
selected.24  72 
As computational tools to aid biodesign become more commonplace, we may begin to see more 73 
uniformity in terms of the types of circuit we see in the literature. However, once they are built, 74 
the process of measuring the behaviour of the designed system (in order to assess its fidelity to 75 
the desired output) may still vary substantially, since few existing workflows consider 76 
measurement, and teams are free to choose their own tools for this stage. Mathematical and 77 
computational modelling have become fundamental tools in synthetic biology, but they are only 78 
effective when combined with useful in vivo observations of synthetic systems. In this workflow, 79 
we describe a methodology for easily mapping simulation results onto laboratory measurements.  80 
4 
Results and discussion 81 
Our overall workflow is depicted in  1. We use a combined experimental in vitro / in silico 82 
approach, the two perspectives being tightly coupled at key points. The various stages are 83 
temporally ordered, from left to right, and we begin once a circuit design is established (that is, 84 
we do not consider issues of circuit design, and instead focus on implementation and 85 
measurement). The first stage in our workflow is Description, in which the design of the desired 86 
construct is captured by some representation(s); this then feeds into the Implementation stage, in 87 
which the construct is built (or modelled). Once the device has been implemented, we perform 88 
Population-level measurement in order to obtain aggregate performance metrics; this then feeds 89 
into a second Implementation phase, which facilitates closer (single-cell) observations. We now 90 
describe each workflow stage in more detail.  91 
Description 92 
In order to obtain reliable and robust circuit performance, it is important to have control over the 93 
vector, and to be able to compare its performance with the same plasmid in multiple scenarios. In 94 
order to achieve this, we use (for the in vivo component) the Standard European Vector 95 
Architecture (SEVA)25 , which is a standard for the physical assembly of vector plasmids and 96 
their nomenclature, as well as an online database of functional sequences and constructs available 97 
to the community. Paired with the SEVA description of the plasmid is a digital representation of 98 
the circuit for the in silico component of the workflow, for which we use the Synthetic Biology 99 
Open Language (SBOL).26 This provides a “standard exchange format" for synthetic biology 100 
designs (between research groups, and between different toolkits).  101 
Implementation 102 
In the first in vitro Implementation phase, the vector is assembled using standard molecular 103 
biology procedures, resulting in the synthesis of circuit modules, and their insertion into the 104 
carrier plasmid. In parallel with this process (i.e., during the in silico implementation phase), we 105 
construct a standardised digital description using SBOL, with one SBOL document per 106 
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construction (File S2). These documents are then combined (using a Java-based tool, Tool S1), 107 
resulting in a single SBOL file containing the sequences of interest in the correct cargo position 108 
according to the restriction enzyme sequences. This tool identifies those SBOL components in 109 
common across components (i.e., the restriction sites) and replaces all the information that exists 110 
in the cargo section from enzyme to enzyme with the cassette of interest. After this step, both the 111 
plasmid containing the circuit and its representation are fully standardised.  112 
Measurements. 113 
The use of mathematical modelling and computational analysis has became a fundamental part of 114 
synthetic biology, due to the information they provide concerning the mechanical behaviour of 115 
the systems. However, this potential can only be used effectively when combined with direct in 116 
vivo measurements.27 Advances in metrology and measuring techniques will obviously benefit 117 
the field of synthetic biology. Recently, attempts have been made to standardise these. Relative 118 
Promoter Units (RPU)28 have emerged as a measuring standard for promoter activity based on a 119 
comparison against a reference promoter. On a more abstract level, the Polymerase Operations 120 
Per Second (PoPs) measure9 is used as the signal carrier in transcriptional circuits. However, 121 
none of these methods are free of controversy.15  122 
In order to simulate the model constructed in the Implementation phase, we use the iBioSim29 123 
tool; conveniently, iBioSim exports reactions to a single Systems Biology Markup Language 124 
(SBML)30 file (File S3), which is a computational standard for the representation of biochemical 125 
networks. Importantly, this allows us to link up the SBML biochemical model of the circuit with 126 
the SBOL description of the DNA components of the circuit, using the methodology described 127 
in.31 In turn, this connects (via SBOL) with the SEVA description of the vector, giving seamless 128 
integration of information across different standards that are used for different levels of 129 
description. We also develop an application (Tool S2, based on libSBML32) to convert a given 130 
SBML file into Python coded scripts, used for for deterministic and stochastic simulations (File 131 
S4). Importantly, the SBML model details (i.e., rates) correspond not only to the circuit itself, but 132 
also its carrier vector. This significantly reduces output variability; by including details of the 133 
vector in the model characterisation (via SEVA/SBML) we take into consideration the possibility 134 
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that the carrier plasmid might later change, due to decisions taken at the implementation phase. 135 
Any such change will, in turn, inevitably (although, sometimes subtly) affect the observable 136 
behaviour of the model when implemented, so including details of the vector allows us to factor 137 
in fluctuations due to variable plasmid selection. 138 
The inclusion of an extra step within the workflow for multicellular analysis will also help to 139 
reduce variability caused by both the chassis and culture conditions. Indeed, both chassis (i.e., P. 140 
putida vs. E. coli) and culture conditions add their own effects to the circuit and its carrier. If the 141 
circuit has to be used under different scenarios we should quantify cellular behaviour. In the 142 
example provided there are behaviours that cannot be measured with the cytometer (i.e., noise 143 
inheritance or cell movement), and which require time-lapse microscopy in order to be quantified. 144 
The parameters corresponding to these behaviours are therefore fitted according to single-cell 145 
measurements. Again, this information adds value to a potential specification sheet that 146 
accompanies the in vivo system.  147 
We use spectophotometry to measure the fluorescent signal of the entire cell population; dividing 148 
this by the optical density (OD) over time yields the average fluorescence value per cell in the 149 
culture. Experimental values are used to fit kinetic rate parameters in the mathematical models so 150 
they produce similar profiles. Importantly, in the graphs that follow, the Y-axis refers to arbitrary 151 
units of fluorescence in experimental observations, and the number of molecules (of, for example, 152 
mCherry proteins) in the simulated observations. Matching the latter with the former gives us an 153 
important reference point concerning measurements, which allows us to interpret subsequent 154 
results.  155 
We perform stochastic analysis in order to characterise noise in the system, using the well 156 
established Gillespie algorithm.33 On the experimental front, we obtain data on noise using flow 157 
cytometry, which allows the user to check the fluorescence intensity value of (in principle) every 158 
single cell in the bacterial culture. Although the ready-to-use graphs produced by the cytometer 159 
(Figure S1) are used as standard in most laboratories, we prefer to use the raw values, before they 160 
are processed for presentation (normally in a “black box" fashion, which is opaque to the user). 161 
There are three main reasons for using raw cytometry data: (1) Cytometers "count" cells using 162 
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variable intervals of fluorescence at high values of a logarithmic scale that is not always constant, 163 
and which depends on a specific machine set-up.  This processing therefore introduces variability 164 
that is hidden from the user; (2) We need cell-specific values in order to make direct comparisons 165 
with simulated cells within our framework; (3) Raw data values are more amenable to importing 166 
and processing by various tool-chain components, whereas the automated extraction of specific 167 
values from graphs produced by cytometers introduces unnecessary complications and the 168 
possibility of misreading data. 169 
A simulated cytometry graph is obtained by running the Python version of the reactions (see 170 
Methods). This offers two potential benefits: firstly, it gives a computational method (via an 171 
SBML model) of discarding invalid values from the raw cytometry information (see the later 172 
Case study for an example). And, secondly, by overlapping both experimental and simulated 173 
plots we are able to correlate the arbitrary units (au) of the cytometer with those from the 174 
spectrophotometer. We propose this procedure as one approach towards unifying machine-based 175 
measurements in the laboratory (and give an example in the Case study, below).  176 
Implementation (2) 177 
The behaviour of our circuit will inevitably be affected by the specific attributes of the host cell. 178 
A thorough characterisation of a device should, therefore, include information about the 179 
performance of the chassis34 (which, in our case, is P.putida KT244035). Rather than simply 180 
providing “added value", this information is of vital importance in the case of multicellular 181 
applications,36,37 which are becoming increasingly important as cell-to-cell communications are 182 
increasingly well-understood and customised.38,39  183 
In order to study the behaviour of circuits in vivo, we use DiSCUS,40 which is an agent-based 184 
simulation package we have previously developed to study bacterial growth. Importantly, this 185 
platform considers physical forces between rod-shaped bacteria, and is applicable to a wide range 186 
of organisms. This tool uses the previously generated Python scripts for the intra-cellular genetic 187 
network that is implemented by our cells. The SBML model is therefore embedded into the 188 
cellular objects of the agent-based simulator. It is important to note that there is a standard, 189 
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currently under development, called the Multi-Cellular Data Standard (MultiCellDS, 190 
http://multicellds.org/), which aims to create a data standard for sharing multicellular 191 
experimental, simulation, and clinical data. Hopefully, when released, it will facilitate sharing of 192 
configuration parameters for a specific chassis performance.  193 
Concurrently, we prepare a 2-dimensional culture on an agarose pad,41 and let the cells grow on 194 
a monolayer in order to facilitate visualisation in the microscope.  195 
Single-cell measurements. 196 
We first calibrate the movement and the growth of the simulated cells according to experimental 197 
observations. We monitor the successive positions of a specific cell until division, and then 198 
follow the displacement of its daughters during their lifetime(s). We then match these results 199 
against the equivalent information obtained from the simulations, and adjust DiSCUS parameters 200 
to fit the experiments. In short (see Methods for more details), this information yields the most 201 
relevant features to prioritise in DiSCUS in order to reproduce the movement of our cells in vivo 202 
(in the Case study, below, we give specific examples).  203 
Spatial measurements. 204 
After characterising the dynamics of the chassis that host our circuit, we measure its performance 205 
in a spatial scenario. We measure the fluorescence intensity of our device in vivo, and obtain a 206 
pixel-based image analysis of the specific colour (in our example, red) captured by the 207 
microscope. In our analysis, we translate the scale bar of the analysis into values proportional to 208 
those used in the mathematical model (see Methods for details of this conversion). As a 209 
consequence, a simulation run with the system’s equations inside DiSCUS bodies, can be directly 210 
compared against experiments in regard to circuit function.  211 
Case study 212 
In this Section we present the results of a combined in vivo/in silico case study, in which we 213 
construct a simple device using our workflow. We start with a simple “always-on" source; that is, 214 
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a constitutive expression cassette. Although this device is relatively simple, compared to existing 215 
synthetic genetic constructs (such as the oscillator), we emphasise that the main focus of the 216 
current paper lies with the measurement of such devices. That is, the complexity of the device to 217 
be constructed is less significant for the purposes of this work, as we are concerned only with 218 
handling its output. Fluorescence measurements are taken in fundamentally the same way, 219 
regardless of the size or complexity of a synthetic device; what interests us here is how we might 220 
standardise such metrics, and relate them back to in silico studies in a useful and meaningful way. 221 
The two subcomponents of the circuit are (1) the pEM7 constitutive promoter, and (2) the red 222 
fluorescence reporter gene mCherry (see Methods for details - File S1). Once the initial design is 223 
in place we move to the Description stage, where the system pEM7-mCherry is digitally 224 
formalised and physically built. The SEVA vector pSEVA 231 (Figure 2B) is selected to carry 225 
the design. This contains a Kanamycin marker (labelled 2), origin of replication pBBR1 (labelled 226 
3), and the default cargo sector (labelled 1). As the cargo sector is a sequence of restriction sites, 227 
we need to select specific locations into which to paste our modules. As depicted in Figure 2A, 228 
we complete the promoter component by flanking the sequences of restriction sites PacI and 229 
AvrII, and using HindIII and SpeI for the reporter gene (this leaves empty space in between for 230 
future usage). Once the Description phase is complete, we move to Implementation.  231 
In Figure 3A we highlight the kinetic rates involved and the Ordinary Differential Equations 232 
(ODEs) that govern the continuous functioning of our always-on device. After cloning, Figure 4A 233 
shows the results for average fluorescence value per cell in the culture, along with deterministic 234 
simulation runs (based on the ODEs) for both the SBML model (implemented using iBioSim) 235 
and its corresponding Python script. We then move to the Population measurement phase.  236 
Figure 4B shows the fluctuations in molecular levels of the reactions of Figure 3A when running 237 
the Gillespie algorithm on the SBML model (iBioSim) and its corresponding Python file. As 238 
expected, the observed variability is the same in both, as the kinetic rates remain unchanged (i.e., 239 
the same as in the ODEs). The mean value is precisely situated on the steady state value of the 240 
deterministic simulation.  241 
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Raw data from the cytometer are plotted on Figure 4C, where the bimodal curve tells that 242 
approximately half of the cells display strong fluorescence, while the rest express none (or very 243 
little). The latter group corresponds to invalid values, and can be discarded, as indicated by the 244 
control data (the same strain without the plasmid) and the already processed graph (Figure S1). 245 
Moreover, further microscope tests show strong fluorescence in all the cells with a relatively 246 
narrow noise interval, which confirms the correct elimination of that non-expressing cell group. 247 
As described in the workflow description, this gives a computationally standard way of 248 
discarding invalid values from raw cytometry information. Moreover, it yields a method for 249 
correlating outputs from different pieces of laboratory equipment. We illustrate this in the graph 250 
of Figure 4C; we are able to correlate the arbitrary units (au) of the cytometer with those from the 251 
spectrophotometer: 1 au in the former, and   1.2 au in the latter (see Methods for more 252 
information). After performing population-level measurements, we move to single-cell 253 
measurements.  254 
5A shows the result of experiments to track cell movements. 5B shows the positions of a cell 255 
(from Figure 5A) until division, and then the displacement of its daughters during their lifetime. 256 
5C shows the most relevant features we need to add in DiSCUS in order to reproduce the 257 
movement of our cells, starting from a very simple growth algorithm (which returns unrealistic 258 
patterns) (Figure 5C.1). Ultimately, we find that we need to include: (1) cell size variations (due 259 
to conditional growth), (2) variation in transversal angles after division, (3) randomised 260 
directions of movement, and (4) slight attraction between cells (in order to avoid the appearance 261 
of holes within the colony).  262 
Figure 5D compares the synchrony of growth within experimental and simulated cells, yielding 263 
suggestions as to how to uncouple growth events. These graphs show the length of each cell in 264 
the population over time (in the laboratory experiments) or iterations (in the simulation). Starting 265 
with just two cells (the same setup as in 5A) which grow and divide at the same time, we observe 266 
that, after the second division (eight cells in total), the length of the cells is no longer 267 
synchronised.  268 
We then consider the spatial scenario. Figure 6A shows the results of measuring the fluorescence 269 
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intensity of our pEM7-mCherry device inside the KT2440 strain, and a pixel-based image 270 
analysis of the red colour captured by the microscope. As stated above, the scale bar of the 271 
analysis is translated into values proportional to those in the mathematical model of 4b. A 272 
simulation run in DiSCUS, using the system’s equations (6B (left)) can be directly compared 273 
against experiments. We verify, for instance, that daughter cells share output levels as they 274 
directly copy their mother’s circuit at a given time (6B), and the fact that cells with slower growth 275 
tend to display a stronger light signal (due to the accumulation of fluorescence proteins).  276 
Discussion and conclusions 277 
Arriving at a fully standardised workflow that allow for robust and reproducible constructs will 278 
benefit synthetic biology. We describe procedures used in our lab to build and measure synthetic 279 
devices, explaining both computational and experimental investigations via a simple use case. 280 
Many recent efforts focus on a specific step depending on application interests. That is the case of 281 
automated circuit design,5,16,18 mathematical modelling,20 single-cell analysis,41 metrology,28 282 
data representation26 or post-construction modification.6 Indeed, there is significant room for 283 
improvement in each step along the workflow. However, instead of focussing on a single 284 
technique, we showed how to make use of several of them in an end-to-end workflow, 285 
concentrating on output measurements. There are recent reviews of other workflows,15 but these 286 
tend to focus on enumeration rather than application of techniques. Apart from the didactic 287 
contribution of this paper, we provide new materials needed for linking standards, such as the 288 
tool to merge SBOL documents for SEVA description, or the scripts to translate SBML into 289 
Python. In this way, we provide a useful initial workflow for newcomers to the field, as well as 290 
(more generally) a standard workflow for robust programmable biology.  291 
Materials and Methods 292 
Strains and plasmids. The strain used was Pseudomonas putida KT2440,35 the wild-type strain 293 
derived from mt-242 strain cured of the TOL plasmid pWW0. The carrier plasmid for our circuit 294 
was pSEVA 231 (2: Kanamycin resistance; 3: pBBR1 origin of replication; 1: default cargo) 295 
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selected from the SEVA database (http://seva.cnb.csic.es/). We then inserted the promoter pEM7 296 
with PacI/AvrII and the mCherry reporter with HindIII/SpeI. The final plasmid was renamed 297 
pSEVA 237R-pEM7 (already available in the database). Importantly, the sequences of interest 298 
(target circuit) were edited to remove any restriction site that the SEVA standard uses as 299 
structural elements.  300 
SBOL-SEVA description. The SEVA format is highly structured in unambiguous functional 301 
sectors, as shown in  2B. We described, using SBOL-2.0 (specifications on the website, 302 
http://sbolstandard.org/), the SEVA vector 231 (Figure S2). The previous existing description of 303 
this vector using GenBank format43 is then improved by adding missing features (like assembly 304 
scars) and establishing structural and functional links. Separately, we produced two more SBOL 305 
documents, one for each component of the circuit. Ultimately, we developed a Java based 306 
application that can be fed with the carrier plasmid and the cassettes that needs to be inserted, and 307 
outputs the new vector. The application searches in the carrier file for those restriction sites 308 
present in the cassettes (iteratively) and substitutes the sequence in between. The resulting SBOL 309 
document has all location parameters (i.e. bioStart) updated.  310 
Mathematical modelling and SBML-to-Python conversion. In the model of Figure 3A, P we 311 
show the promoter-reporter pair (18 copies, as estimated by previous observations for pBBR1 312 
origin of replication44), mRNA the messenger RNA and rfp the red fluorescent protein (both at 0 313 
molecules at the beginning of the simulation). Regarding the kinetic rates: k1 is the transcription 314 
rate (27/18 hour-1, k2 represents the translation rate (2.5 hour-1) and k3 (0.65 hour-1) and k4 (0.265 315 
hour-1) the degradation rates of the mRNA and the protein respectively. For such a small network, 316 
parameter assignment is a difficult task due to the restricted number of constraints. Efforts on 317 
assigning numbers to rates45 are of vital importance at this stage.  318 
We then used the software iBioSim (http://www.async.ece.utah.edu/iBioSim/) to write the model 319 
in SBML format and run the simulations with the Hierarchical Runge-Kutta method for ODEs 320 
solution, and the Gillespie algorithm for stochastic behaviour. The model was exported in a flat 321 
(iBioSim option) XML file and converted into Python scripts with the tool provided (Tool S2). 322 
Flow cytometry data was obtained from the FCS files without processing, and the simulated 323 
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graph was obtained by (1) sampling a stochastic run in time (equal time intervals), and (2) 324 
counting intensity values over a long enough (≈ 600 hours) period.  325 
By making the simulations match experimental plots in Figure 4A, we conclude that  400 326 
simulated molecules (s.m.) correspond to ≈400 arbitrary units in the spectrophotometer (a.u.s). 327 
As the computational measurements (s.m.) in the stochastic simulation are exactly the same, we 328 
used them to correlate the fluorescent units of the cytometer (a.u.c). As Figure 4C shows, ≈400 329 
s.m. = ≈330 a.u.c; so 1 a.u.s = 400/330 a.u.c. We assume that the sources of fluorescent signal are 330 
the same, as the cells are unaltered.  331 
Two-dimensional in-vivo setup. In order to prepare of the microscope sample, we used an 332 
agarose pad following the method described in.46 A slide glass with an attached gene frame (1.7 333 
X 2.8 cm, life technologies) was prepared. Then 500 ul of LB, including 2% agarose, which is 334 
melted in the medium, was added into the middle of the gene frame and assembled with another 335 
slide glass. After 30 min at room temperature, one of the slide glasses was carefully removed, 336 
maintaining an intact agarose pad. Then, the pad was cut out to 5 mm width within the gene 337 
frame using a razor blade. Two strips of the pad were left to grow bacterial cells.  338 
The strain carrying pSEVA 237R-pEM7 was precultured overnight in LB medium at 37 C and 339 
bacterial cultures were then diluted 100-fold in the same medium and grown to the exponential 340 
phase (OD600 = 0.2). 2.5 ul of the samples were then spotted on to the agarose pad and 341 
assembled with cover glasses (24 X 50 mm) for following microscopy analysis.  342 
The widefield fluorescent microscope was used to observe the sample (Leica DMI6000B, Leica 343 
Microsystems) with a digital CCD camera Orca-R2 (Hamamatsu). The cell growth was 344 
monitored for 75 min under the microscope at 37º C and images were captured every 3 min with 345 
a40.0x/0.75 NA dry objective or 63.0x/1.3 NA glycerol immersion objective (depending on the 346 
experiment) with a bandpass filter for mCherry (BP 560/40 and EM 645/75.) using the LAS AF v. 347 
2.6.0 software (Leica Microsystems). Images were analyzed with the MATLAB-based code 348 
Schnitzcells47 in order to track both the positions of the cells and their length while growing.  349 
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Two-dimensional in-silico setup. DiSCUS (http://code.google.com/p/discus/) is an agent-based 350 
software for bacterial growth that uses Pymunk (http://pymunk.readthedocs.org/en/latest/), a 2D 351 
physics library, to resolve collisions among cells. In the most basic test of Figure 5C.1 each cell 352 
is a body of 16x30 square lattice that grows lengthwise until division, when the cell is cut in half. 353 
Pressure-based growth is simulated by counting the cells that push a body of interest (threshold at 354 
4 cells) and slowing down the growth events (without stopping them). Random angle variations 355 
were introduced after division, whereby the daughter cells copy the angle of the mother and add a 356 
number in the interval (-25,25) degrees. Furthermore, angle variations were included at the 357 
normal growth events, although to a smaller extent (maximum variation of 5 degrees). The fact 358 
that the cells grow in vivo forming a circular group without holes was simulated using a slight 359 
gravity-like value that pushed the cells towards the middle of the population. This force can be 360 
eliminated when the population is about 20 cells big, at which point the circular shape is 361 
conserved without any other attraction. Further analysis on this force is needed.  362 
Regarding pixel intensity in the analysis of Figure 6A, we set the maximum value to be at the 363 
same level as the highest peak of the stochastic simulation of Figure 4B or the cytometry data of 364 
Figure 4C. Therefore we calculated the percentage rate (≈470*100 divided by maximum pixel 365 
value) to convert the intensity of every pixel into the scale shown by experiments. Again, we 366 
assume that the source of light is the same (KT2440) and variances are due to different machine 367 
measurements.  368 
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Supporting Information Legends 495 
File S1. Sequences of promoter pEM7 and gene mCherry. 496 
File S2. SBOL files. For a) plasmid, b) promoter and c) reporter.  497 
Tool S1. Software tool to merge SBOL files and insert cassettes into a vector.  498 
File S3. SBML files.  499 
File S4. Annotated SBML file.  500 
Tool S2. Software tool to convert a SBML model into a Python script.  501 
File S5. Python scripts  502 
Figure S1. Cytometry results. Graph output by cytometer after processing.  503 
 504 
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Figure Legends 505 
Figure 1: Workflow for an end-to-end synthetic biology use case. The description that follows 506 
(and modify) the design of an idea is the starting point for the consequent experimental and 507 
computational methods. The circuit and its carrier vector are described using the SEVA (Standard 508 
European Vector Architecture) format for the in-vivo workflow and the SBOL (Synthetic 509 
Biology Open Language) standard for the parallel in-silico process. A first implementation round 510 
is then performed via synthesis and cloning methods in the wet-lab and via SBML (Systems 511 
Biology Markup Language) for the modelling. The resulting material is then used for different 512 
measurements. First, we make use of usual laboratory equipment for population-based 513 
experiments (spectophotometry and flow cytometry) to compare the output against simulation 514 
software (iBioSim and ad hoc python code). Another implementation round prepares the samples 515 
for single-cell measurements. On the computational side, the SBML model is exported to a 516 
python script ready to be used with our software for cell movement DiSCUS (Discrete 517 
Simulation of Conjugation Using Springs). Relevant efforts are being currently done to 518 
standardise these simulations via the MultiCellDS (Multi Cellular Data Standard) project. On the 519 
other side, the cells are grown on an agarose pad for 2-dimensional populations that allow us to 520 
match results.  521 
21 
Figure 2: SBOL description of circuit and SEVA components. A. Circuit design modification 522 
where the components are flanked by the selected restriction sites that specify their situation 523 
inside the SEVA vector. The constitutive promoter pEM7 is surrounded by PacI and AvrII 524 
whereas the reporter mCherry is bordered by HindIII and SpeI. An SBOL document per 525 
component is created. B. The selected SEVA plasmid to harbour our circuit is SEVA number 231 526 
(2: Kanamycin resistance; 3: pBBR1 origin of replication; 1: default cargo). All vector features 527 
are recorded in a single SBOL document, including cargo (multiple cloning site) components for 528 
a further assembling of circuit parts. C. Both in-vivo and in-silico protocols for building the final 529 
construct have the same basics: introduce, sequentially, circuit parts in the carrier vector. A 530 
software tool (Tool S1) allows to do so with SBOL documents.  531 
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 532 
Figure3: Mathematical modelling and its SBML format A. Kinetic reactions (up) and system’s 533 
differential equations (bottom). The circuit’s behaviour can be effectively simulated with just 534 
four kinetic constants: the constitutive promoter P facilitates reporter transcription with rate k1, 535 
resulting mRNA is translated with rate k2 leading to the formation of RFP (red fluorescent 536 
protein) and both elements are degradated with rates k3 and k4 respectively. ODEs (Ordinary 537 
Differential Equations) governing continuous dynamics are shown. B. Schema of the SBML 538 
model produced with the software iBioSim, a CAD (computer-aided design) package for systems 539 
biology. In the screenshot, blue elements represent substrates and red circles hide reaction rates. 540 
After setting the parameters, iBioSim allows the user to export the model to an XML file 541 
formatted following the SBML standard.  542 
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Figure 4: Population-based measurements in experimental and simulation setups. A. 543 
Deterministic functioning of the circuit, in terms of fluorescence intensity over time (during 14 544 
hours), averaging the value of the whole population. Red line corresponds to experimental results, 545 
while blue and black lines show simulation runs of the model’s differential equations with 546 
iBioSim and python code respectively. Experimental values are used to fit rate numbers in 547 
mathematical models so they produce similar continuous lines. B. Stochastic behaviour of the 548 
system according to simulations. The blue line results of running the Gillespie algorithm with 549 
iBioSim whereas the black line shows the python script behaviour. As expected (same algorithm 550 
with equal parameters), the fluctuations are alike. C Fluorescence intensity values of each cell in 551 
the population measures variability and expression noise. Experimental raw data extracted by 552 
flow cytometry (without processing by the cytometer, see text for details) corresponds to the red 553 
line. Black line results from counting expression values in the simulation with the python script, 554 
while grey area represents the control (plasmid-free cells) measured experimentally. Note that 555 
scales are different in simulation and experimental lines, standing for variability within arbitrary 556 
units (a.u.).  557 
24 
 558 
Figure 5: Characterisation of chassis mechanics. A. Tracking cell lineages in a experimental 559 
setup. Starting from the division of a single cell (up) we follow the movement of its daughters 560 
(middle and bottom) in order to define their movement behaviour until next division. B. Position 561 
coordinates are recorded during the experiment (red line) and simulation (black line) to fit 562 
parameters by comparing both outputs. Cell traces are overlapped for visualisation purposes and 563 
axis rotated accordingly to show dimensions. C. Parameter estimation for cell movement. 564 
Different features are included, sequentially, in order to get the final moving procedure for in-565 
silico simulations. Starting from inaccurate movement (C.1) we add size variability due to 566 
pressure (C.2), random angles after division (C.3), irregular motion changes (C.4) and slight cell 567 
attraction to simulate viscous bodies (C.5). All simulations start from a single cell, and one 568 
lineage is coloured to monitor coordinate positions. D. Synchrony of cell growth. The length of 569 
25 
each cell (y axis) is monitored over time (x axis) in both scenarios (experiment, up; simulation, 570 
bottom). The initial cells grow at the same time until division point is reached, whereas the third 571 
generation of cells grow asynchronously.  572 
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Figure 6: Spatial progress of the genetic device. A. Phase contrast image of population (left), 573 
fluorescent picture (middle) and computational analysis (right). In the latter, the colour scheme 574 
(right bar) represents the value of the red channel of every pixel from 0 to 255. However it is 575 
transformed into a [0..450] scale in order to allow comparisons with previous fluorescence 576 
measurements. B. On the left, we show a simulation of a colony starting from a single cell. 577 
Upper-left arrow highlights cells with slower growth rate and RFP accumulation while bottom-578 
right arrow points at a recently divided cell where both daughters share similar RFP 579 
concentration. On the right, expression noise inheritance is indicated with an arrow. Furthermore, 580 
RFP accumulation caused by slow growth can be observed by the black line separation: a single 581 
cell started from each side.  582 
